Limb-girdle muscular dystrophy 2D, alpha-sarcoglycan deficiency (Q86052): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:25, 15 August 2026
Autosomal recessive limb-girdle muscular dystrophy (LGMD) type 2D belongs to the group of LGMD, that are genetically determined, progressive muscle weakness disorders, in which the pelvic or shoulder girdle musculature is predominantly or primarily involved. LGMD2D is a sarcoglycanopathy characterised by scapular winging and calf hypertrophy with cardiac involvement in about 20% of cases.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1066309170 |
||
| English | Limb-girdle muscular dystrophy 2D, alpha-sarcoglycan deficiency |
Autosomal recessive limb-girdle muscular dystrophy (LGMD) type 2D belongs to the group of LGMD, that are genetically determined, progressive muscle weakness disorders, in which the pelvic or shoulder girdle musculature is predominantly or primarily involved. LGMD2D is a sarcoglycanopathy characterised by scapular winging and calf hypertrophy with cardiac involvement in about 20% of cases. |
Statements
CID11:ID_1066309170
0 references
dki-india-ID_1066309170
0 references
Concluído
0 references
13 August 2026
0 references
